UBS Maintains Buy on Abbott Laboratories, Lowers Price Target to $125

Benzinga · 1d ago
UBS analyst Patrick Wood maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price target from $135 to $125.